Welcome to the Biologics Section of SpineTechNews.com, where you can find the latest news about Biologics. Check back here often for new and useful products. Your back pain is history!
Mesoblast will use the funds to expand the company’s clinical trial programs focusing on the company’s stem cell based bone and cartilage regenerative products for spinal vertebral disc disease.
Read MoreGlobus Medical, Inc., the largest privately held spinal implant manufacturer in the world, announced the launch of MicroFuse ST Granules, a unique resorbable polymer bone void filler optimized for both strength and porosity.
Read MoreThe allowed claims within this patent application cover compositions of platelet derived growth factor (PDGF) combined with matrix materials having defined characteristics, which cover the Company’s novel recombinant protein-device combination product candidates.
Read MoreInfuse Bone Graft is a man-made liquid form of bone morphogenetic protein. It is implanted between vertebrae soaked in a sponge-like substance enclosed in a metallic cage.
Read MoreMagniFuse (TM) line of next generation bone regeneration products was developed in response to surgeon interest in a high performing, cost effective bone graft material.
Read MoreApaTech, announced the global launch of ActifuseTM MIS, a unique, purpose designed applicator that provides unprecedented access to the graft site for surgeons.
Read MoreIs there any data available comparing the use of tantalum implants to bone grafts for anterior cervical fusion?
Read MoreOsteotech’s Plexur P bone filler was recently awarded FDA approval for use in the spine.
Read MoreIs Vertigraft VG1 graft any different from the spinal fusion products currently on the market?
Read More